He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.
In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.
In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.
In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.
In this 2-minute video, Barak Gaster, MD, talks about identifying mild cognitive impairment in primary care, a topic he is also speaking about at our Practical Updates in Primary Care 2020 Virtual Series on...
In this 2-minute video, Barak Gaster, MD, talks about identifying mild cognitive impairment in primary care, a topic he is also speaking about at our Practical Updates in Primary Care 2020 Virtual Series on...
In this 2-minute video, Barak Gaster, MD, talks about identifying mild cognitive impairment in primary care, a topic he is also speaking about at our Practical Updates in Primary Care 2020 Virtual Series on...
